Jazz Pharmaceuticals PLC (JAZZ) stock news · rev $4.27B
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
This JAZZ news page leads with what Jazz Pharmaceuticals PLC filed — not a scraped headline mill.
No cached 8-K sentence for JAZZ yet. We will not pad this page with generic market recap.
Latest reported JAZZ revenue for 2025-12-31 was $4.27B. Net income was -$356.1M. Revenue was up 4.9% from 2024-12-31 to 2025-12-31. JAZZ currently screens at market cap $14.97B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the JAZZ stock page; for the tape open the quote page.
JAZZ stock news FAQ
What are JAZZ's latest revenue and net income?
Latest cached Jazz Pharmaceuticals PLC (JAZZ) revenue for Dec 31, 2025 was $4.27B. Net income was -$356.1M. Statements: https://lician.com/financials/jazz
How did JAZZ revenue change from the prior cached period?
Cached Jazz Pharmaceuticals PLC (JAZZ) revenue was up 4.9% from $4.07B (Dec 31, 2024) to $4.27B (Dec 31, 2025). Statements: https://lician.com/financials/jazz
What is JAZZ's market cap?
Jazz Pharmaceuticals PLC (JAZZ) market cap is $14.97B on the latest cached fundamentals snapshot.
What kind of company is JAZZ?
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Where is JAZZ stock news listed?
Cached stock news for Jazz Pharmaceuticals PLC (JAZZ) is listed at https://lician.com/news/jazz. Filings: https://lician.com/sec/jazz
Not investment advice.